FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, particularly to the addiction pharmacology, and concerns new application of threonyl-lysyl-prolyl-arginyl-prolyl-glycyl-prolyl-diacetate (Selank) as an agent for managing alcohol abstinence syndrome (AAC). It has been stated that Selank eliminates anxiety induced by withdrawal of ethanol. Selank has been detected to recover a threshold of tactile sensation reduced in the period of alcohol withdrawal to the level observed in intact animals.
EFFECT: anxiolytic Selank can be applied as the effective agent for correction of clinical manifestations of mild and moderate alcohol abstinence syndrome with no adverse side effects.
7 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LOW MOLECULAR WEIGHT MIMETIC OF BRAIN NEUROTROPHIC FACTOR WITH ANALGESIC, ANXIOLYTIC AND ANTIADDICTIVE EFFECTS | 2020 |
|
RU2759023C2 |
| CARDIOTROPIC AGENT WITH ANXIOLYTIC AND ANALGESIC PROPERTIES | 2020 |
|
RU2773018C2 |
| APPLICATION OF LITHIUM ASCORBATE FOR PREVENTION AND TREATMENT OF CHRONIC ALCOHOLIC INTOXICATION | 2017 |
|
RU2639496C1 |
| ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
| ANXIOLYTIC AND CEREBROPROTECTIVE AGENT REDUCING INCLINATION TO ALCOHOL | 2008 |
|
RU2393855C1 |
| ANTIANXIETY DRUGS AND PHARMACEUTICAL COMPOSITIONS WITH ANXIOLYTIC EFFECTS | 2014 |
|
RU2580311C1 |
| AGENT POSSESSING ANXIOLYTHIC ACTION, ON BASIS OF HYDROGENATED PYRIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND WAY OF ITS APPLICATION | 2007 |
|
RU2338533C1 |
| PEPTIDE POSSESSING NEUROTROPIC PROPERTIES | 2011 |
|
RU2443711C1 |
| PEPTIDE POSSESSING NEUROTROPIC PROPERTIES | 2011 |
|
RU2443712C1 |
| MEANS FOR REDUCING ALCOHOL MOTIVATION IN ALCOHOL DEPENDENCE | 2014 |
|
RU2582966C2 |
